Subscribe: Latest / All - Designed by Dr James P Howard (Google+)
GUSTO-III TRIAL |
|
|---|---|
| Problem | Suspected acute MI |
| Format | - |
| Treatment | Alteplase OR Reteplase |
| Control | Streptokinase |
| Population | 15059 patients with MI symptoms between 30min and 6 hours |
| Inclusion criteria | - |
| Exclusion criteria | - |
| Follow-up | 30 days and 1 year |
| Primary endpoint | All cause mortality |
| Secondary endpoint(s) | - |
| Details | . |
| Brief summary: | |
| PAPER: Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded... | |
|---|---|
| Date | 10 Oct 2000 |
| Journal | Circulation. 2000 Oct 10;102(15):1761-5. |
| Information | -No significant difference in mortality between reteplase and alteplase at 30 days and 1 year |